ZBH
Zimmer Biomet·NYSE
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 5
Bearish signal 2
Consensus Rating "Strong Buy"
Ample Liquidity
High Gross Profit Margin
High Cash/net Profit Ratio
Low Cash Short-term Debt Ratio
Revenue Beats Expectation
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About ZBH
Zimmer Biomet Holdings, Inc.
A global medical technology leader that develops orthopedic and dental reconstructive implants, trauma products and related surgical products
Healthcare Equipment and Supplies
--
07/27/2001
New York Stock Exchange
17,000
12-31
Common stock
345 East Main Street, Warsaw, Indiana 46580
Design, manufacture and market orthopedic reconstruction products; sports medicine, biologics, extremities and trauma products; spine, bone healing, cranio-maxillofacial, thoracic products; dental implants; and related surgical products
Zimmer Biomet Holdings, Inc. was incorporated in Delaware in 2001. The company's history can be traced back to 1927, when its predecessor, Zimmer Manufacturing Company, was founded in Warsaw, Indiana. The company is a global medical technology leader with a comprehensive product portfolio designed to maximize liquidity and improve health. The company designs, manufactures and markets orthopedic reconstruction products; sports medicine, biologics, limb and trauma products; craniofacial and thoracic products; surgical products; and a suite of integrated digital and robotics technologies that utilize data, data analysis and artificial intelligence.
Earnings Call
Q1/2025
Estimate EPS1.77
Actual EPS1.81
Estimate Revenue1.90B
Actual Revenue1.91B
Zimmer Biomet's Q1 2025: Unpacking Contradictions in Tariff Strategy, ASC Growth, and Product Launches
May 05,2025 07:41
Earnings Decrypt
Earnings Decrypt
Q2/2025
Estimate EPS1.98
Actual EPS2.07
Estimate Revenue2.06B
Actual Revenue2.08B
Zimmer Biomet's Q2 2025: Unpacking Contradictions in Pricing, Growth, and Integration Strategies
Aug 07,2025 03:31
Earnings Decrypt
Earnings Decrypt
Q3/2025
Estimate EPS1.87
Actual EPS1.9
Estimate Revenue2.01B
Actual Revenue2.00B
Zimmer Biomet's Q3 2025: Contradictions Emerge on Guidance, Restorative Therapies, and Innovation
Nov 05,2025 01:02
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
ZBH has released its 2025 Q3 earnings. EPS was reported at 1.9, versus the expected 1.87, beating expectations. The chart below visualizes how ZBH has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
ZBH has released its 2025 Q3 earnings report, with revenue of 2.00B, reflecting a YoY change of 9.71%, and net profit of 231.20M, showing a YoY change of -7.22%. The Sankey diagram below clearly presents ZBH's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
